This Early Long COVID Clinic Was Led by PM&R and Family and Internal Medicine
The University of Washington in Seattle opened one of the country's first long COVID clinics, staffed by specialists in rehabilitation and primary care.
Daily Dose: Keto Diet and Cardiovascular Health
Your daily dose of clinical news you may have missed.
Electronic “Nudges” Linking Flu Vaccination to Potential CV Benefits Boosted Uptake in Older Adults in Denmark
ACC 2023. Electronic nudges highlighting the potential cardiovascular benefits of flu vaccination led to a modest uptake in vaccination rates among older adults in Denmark, according to results of the NUDGE-FLU trial.
Daily Dose: Coordinated Care to Optimize CV Preventive Therapies in T2D
FDA Accepts sNDA for Empagliflozin for Children with Type 2 Diabetes Aged 10 Years and Older
The SGLT-2 inhibitor, if approved for this age group, would be the first agent in the class with the indication as adjunctive treatment for T2D for those younger than age 18.
Residual Inflammation in Statin-treated Patients Linked to Greater Risk for MACE, Mortality vs Residual Cholesterol
Among patients in the highest quartile of hsCRP, the risks of CV-related and all-cause death were more than 2 times higher than in those in the highest quartile of LDL-C.
A Primary Care Physician and a Physiatrist Share Notes on Sharing Patients
In a multidisciplinary primary care outpatient clinic, PCP Maisterra and physiatrist McMullen confer and refer on a regular basis and patients always win.
Ketogenic Diet Associated with Increased Serum Lipids, 2-fold Greater Risk of MACE
ACC2023. Risk for MACE was nearly 7-fold higher in participants on a keto diet whose LDL-C was already high compared with those on a standard diet with LDL-C in a normal range.
Bempedoic Acid May be Effective Alternative for Statin-intolerant Patients, According to Data from CLEAR Outcomes Trial
ACC 2023. In the CLEAR Outcomes trial, bempedoic acid reduced risk for major CV events by 13% compared with placebo in patients who had, or were at high risk for, CVD.
Likelihood of Optimal GDMT for Patients with T2D, ASCVD Increased with Multifaceted Clinic Intervention
ACC2023. For high-risk T2D patients not receiving optimal treatment for hyperlipidemia, hypertension, or hyperglycemia, intensive, multidisciplinary training for clinic staff could shift practice.
Depression, Anxiety More Common Among Teenagers, Young Adults Who Vape Marijuana and Nicotine
About 60% of dual vapers experienced depression and 52% experienced anxiety, according to findings from a survey of over 2500 youth and young adults.
Primary Care and Physical Medicine & Rehab: In Conversation
Two clinicians from a multispecialty primary care outpatient clinic in Seattle talk about how they work together and the benefits of sharing their space and their patients.
Daily Dose: Mediterranean Diet & Risk of CVD in Women
US Teen Substance Use in 2021: By the Numbers
Substance use among teenagers decreased for some substances from 2011 to 2021, but there is still progress to be made, according to the latest CDC Youth Risk Behavior Survey.
COVID-19 Reinfection: Snapshot of the Pathology
Data presented at CROI 2023 demonstrated that periods of reinfection with the virus correlated with ascent of new variants and with time since first infection.
Mediterranean Diet Beneficial for Prevention of Heart Disease, Death in Women
ACC 2023. The Mediterranean diet has a beneficial effect on the primary prevention of cardiovascular disease and death in women, according to new analysis.
Post-CABG Risk Remains Higher for Women vs Men with No Change Over Last 10 Years
After coronary artery bypass surgery, women are still at higher risk for MI, stroke, and other adverse events than men despite years of improvement in technique and care.
Daily Dose: Impact of Air Pollution on Bone Mineral Density in Women
13 Medications to Avoid in Adults with Hypertension: A Guideline Topline for Primary Care
Reduce potential for promoting or worsening hypertension by stopping, reducing, or using alternatives to these 13 drugs and substances.
Patients with CVD and Type 2 Diabetes and Chronic Kidney Disease are at Extremely High Risk for MACE
ACC 2023. Type 2 diabetes and CKD in patients with CVD are mutually independent predictors of MACE, concluded authors of a new study.
